Annual Net Income:
-$366.25M-$212.64M(-138.43%)Summary
- As of today, CRSP annual net profit is -$366.25 million, with the most recent change of -$212.64 million (-138.43%) on December 31, 2024.
- During the last 3 years, CRSP annual net income has fallen by -$743.91 million (-196.98%).
- CRSP annual net income is now -196.98% below its all-time high of $377.66 million, reached on December 31, 2021.
Performance
CRSP Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
-$208.55M-$72.55M(-53.35%)Summary
- As of today, CRSP quarterly net profit is -$208.55 million, with the most recent change of -$72.55 million (-53.35%) on June 30, 2025.
- Over the past year, CRSP quarterly net income has dropped by -$82.14 million (-64.98%).
- CRSP quarterly net income is now -127.47% below its all-time high of $759.23 million, reached on June 30, 2021.
Performance
CRSP Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
-$467.80M-$82.14M(-21.30%)Summary
- As of today, CRSP TTM net profit is -$467.80 million, with the most recent change of -$82.14 million (-21.30%) on June 30, 2025.
- Over the past year, CRSP TTM net income has dropped by -$201.99 million (-75.99%).
- CRSP TTM net income is now -204.75% below its all-time high of $446.58 million, reached on June 30, 2021.
Performance
CRSP TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
CRSP Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -138.4% | -65.0% | -76.0% |
| 3Y3 Years | -197.0% | -12.2% | +26.1% |
| 5Y5 Years | -647.8% | -161.8% | -121.4% |
CRSP Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -197.0% | +43.7% | -333.4% | at low | -204.5% | +31.3% |
| 5Y | 5-Year | -197.0% | +43.7% | -127.5% | at low | -204.8% | +31.3% |
| All-Time | All-Time | -197.0% | +43.7% | -127.5% | at low | -204.8% | +31.3% |
CRSP Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$208.55M(-53.3%) | -$467.80M(-21.3%) |
| Mar 2025 | - | -$136.00M(-264.5%) | -$385.66M(-5.3%) |
| Dec 2024 | -$366.25M(-138.4%) | -$37.31M(+56.6%) | -$366.25M(-52.9%) |
| Sep 2024 | - | -$85.94M(+32.0%) | -$239.59M(+9.9%) |
| Jun 2024 | - | -$126.41M(-8.4%) | -$265.80M(-22.4%) |
| Mar 2024 | - | -$116.59M(-230.5%) | -$217.14M(-41.4%) |
| Dec 2023 | -$153.61M(+76.4%) | $89.35M(+179.7%) | -$153.61M(+56.5%) |
| Sep 2023 | - | -$112.15M(-44.3%) | -$353.53M(+15.0%) |
| Jun 2023 | - | -$77.74M(-46.5%) | -$415.93M(+20.6%) |
| Mar 2023 | - | -$53.06M(+52.0%) | -$524.02M(+19.4%) |
| Dec 2022 | -$650.17M(-272.2%) | -$110.58M(+36.7%) | -$650.17M(+4.5%) |
| Sep 2022 | - | -$174.55M(+6.1%) | -$680.85M(-7.5%) |
| Jun 2022 | - | -$185.83M(-3.7%) | -$633.45M(-303.3%) |
| Mar 2022 | - | -$179.22M(-26.9%) | $311.61M(-17.5%) |
| Dec 2021 | $377.66M(+208.3%) | -$141.25M(-11.1%) | $377.66M(-8.3%) |
| Sep 2021 | - | -$127.15M(-116.7%) | $411.87M(-7.8%) |
| Jun 2021 | - | $759.23M(+770.9%) | $446.58M(+213.8%) |
| Mar 2021 | - | -$113.16M(-5.7%) | -$392.30M(-12.4%) |
| Dec 2020 | -$348.87M | -$107.04M(-15.8%) | -$348.87M(-65.1%) |
| Sep 2020 | - | -$92.44M(-16.0%) | -$211.28M(-1179.2%) |
| Jun 2020 | - | -$79.66M(-14.2%) | $19.58M(-57.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$69.73M(-328.3%) | $45.53M(-31.9%) |
| Dec 2019 | $66.86M(+140.5%) | $30.54M(-77.9%) | $66.86M(+693.0%) |
| Sep 2019 | - | $138.42M(+357.8%) | -$11.27M(+94.4%) |
| Jun 2019 | - | -$53.70M(-10.9%) | -$200.41M(-8.3%) |
| Mar 2019 | - | -$48.41M(-1.7%) | -$185.09M(-12.2%) |
| Dec 2018 | -$164.98M(-141.4%) | -$47.59M(+6.2%) | -$164.98M(-40.7%) |
| Sep 2018 | - | -$50.71M(-32.1%) | -$117.25M(-28.5%) |
| Jun 2018 | - | -$38.38M(-35.6%) | -$91.25M(-21.4%) |
| Mar 2018 | - | -$28.30M(>-9900.0%) | -$75.18M(-10.0%) |
| Dec 2017 | -$68.36M(-194.6%) | $140.00K(+100.6%) | -$68.36M(-33.0%) |
| Sep 2017 | - | -$24.71M(-10.7%) | -$51.40M(-24.2%) |
| Jun 2017 | - | -$22.32M(-3.9%) | -$41.39M(-14.2%) |
| Mar 2017 | - | -$21.48M(-225.6%) | -$36.23M(-56.2%) |
| Dec 2016 | -$23.20M(+10.2%) | $17.10M(+216.4%) | -$23.20M(+42.4%) |
| Sep 2016 | - | -$14.69M(+14.4%) | -$40.30M(-57.4%) |
| Jun 2016 | - | -$17.16M(-103.3%) | -$25.61M(-111.5%) |
| Mar 2016 | - | -$8.44M(-130.3%) | -$12.11M(-68.4%) |
| Dec 2015 | -$25.83M(-279.8%) | - | - |
| Jun 2015 | - | -$3.67M(-4.1%) | -$7.19M(-104.1%) |
| Mar 2015 | - | -$3.52M | -$3.52M |
| Dec 2014 | -$6.80M | - | - |
FAQ
- What is CRISPR Therapeutics AG annual net profit?
- What is the all-time high annual net income for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual net income year-on-year change?
- What is CRISPR Therapeutics AG quarterly net profit?
- What is the all-time high quarterly net income for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly net income year-on-year change?
- What is CRISPR Therapeutics AG TTM net profit?
- What is the all-time high TTM net income for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG TTM net income year-on-year change?
What is CRISPR Therapeutics AG annual net profit?
The current annual net income of CRSP is -$366.25M
What is the all-time high annual net income for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual net profit is $377.66M
What is CRISPR Therapeutics AG annual net income year-on-year change?
Over the past year, CRSP annual net profit has changed by -$212.64M (-138.43%)
What is CRISPR Therapeutics AG quarterly net profit?
The current quarterly net income of CRSP is -$208.55M
What is the all-time high quarterly net income for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly net profit is $759.23M
What is CRISPR Therapeutics AG quarterly net income year-on-year change?
Over the past year, CRSP quarterly net profit has changed by -$82.14M (-64.98%)
What is CRISPR Therapeutics AG TTM net profit?
The current TTM net income of CRSP is -$467.80M
What is the all-time high TTM net income for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM net profit is $446.58M
What is CRISPR Therapeutics AG TTM net income year-on-year change?
Over the past year, CRSP TTM net profit has changed by -$201.99M (-75.99%)